

(Alliance News) - ValiRx PLC on Monday said subsidiary Inaphaea BioLabs has agreed an exclusive licensing deal with Dominion Biotech Ltd for Inaphaea'...


(Corrects the name of the AJ Bell analyst quoted.)


(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth u...


(Alliance News) - Stock prices in London were higher at midday on Friday, amid a slight lull in tensions over the Israel-Iran conflict after US Presid...


(Alliance News) - ValiRx PLC shares surged on Friday as it said Ambrose Healthcare Ltd has exercised its option to licence its VAL401 asset for GBP16 ...


(Alliance News) - ValiRx PLC on Tuesday said subsidiary Cytolytix Ltd has entered an evaluation and material transfer agreement with California-based ...


ValiRx PLC - Essex-based life sciences company focusing on early-stage cancer therapeutics and women's health - signs an extension to the evaluation a...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: